IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $275,000 | +67.7% | 37,000 | +32.1% | 0.16% | +61.4% |
Q3 2021 | $164,000 | -11.4% | 28,000 | 0.0% | 0.10% | -18.5% |
Q2 2021 | $185,000 | -38.3% | 28,000 | -24.3% | 0.12% | -35.1% |
Q1 2021 | $300,000 | +22.4% | 37,000 | -2.6% | 0.19% | +23.2% |
Q4 2020 | $245,000 | +145.0% | 38,000 | +35.7% | 0.16% | +98.7% |
Q3 2020 | $100,000 | -56.1% | 28,000 | -43.4% | 0.08% | -60.2% |
Q2 2020 | $228,000 | +34.9% | 49,500 | 0.0% | 0.20% | +18.1% |
Q1 2020 | $169,000 | -46.2% | 49,500 | -19.5% | 0.17% | -35.2% |
Q4 2019 | $314,000 | +110.7% | 61,500 | 0.0% | 0.26% | +69.5% |
Q3 2019 | $149,000 | -3.9% | 61,500 | -14.0% | 0.15% | +104.1% |
Q2 2019 | $155,000 | -3.7% | 71,500 | +20.2% | 0.07% | +17.5% |
Q1 2019 | $161,000 | -51.1% | 59,500 | -13.1% | 0.06% | -58.8% |
Q4 2018 | $329,000 | -12.3% | 68,500 | +73.4% | 0.15% | +4.1% |
Q3 2018 | $375,000 | -2.3% | 39,500 | 0.0% | 0.15% | 0.0% |
Q2 2018 | $384,000 | – | 39,500 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |